❌

Normal view

A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases

Nature, Published online: 10 June 2026; doi:10.1038/s41586-026-10633-1

Linafexor is a rapidly cleared FXR agonist designed to mimic natural bile acid signalling, achieving transient receptor activation with strong efficacy and reduced toxicity in preclinical and early clinical studies.

Enabling superior high-temperature capacitive performance in polymer dielectrics by multifunctional alternating nanolaminate coating

Energy Environ. Sci., 2026, 19,3261-3270
DOI: 10.1039/D6EE00769D, Paper
Yuqi Liu, Jiufeng Dong, Kaixin Liu, Chengyuan Wang, Yujuan Niu, Liang Sun, Shuoyan Liu, Jiangyu Li, Jiannong Wang, Hong Wang
An alternating Al2O3/ZrO2 nanolaminate coating on polymers delivers a record discharged energy density of 8.50 J cmβˆ’3 with 96.4% efficiency at 150 Β°C via synergistic charge-injection blocking, deep trapping, and lateral electric field redistribution.
The content of this RSS Feed (c) The Royal Society of Chemistry
❌